Page 843 - Cardiac Nursing

9-8
22.
22.
a
Pa
9-8
19
ar
Apt
009
p79
0
19
/
0
9
g
e 8
2
009
9
6
M
9 P
5
3
3
Pa
d
2
LWB
LWBK340-c35_p799-822.qxd 29/06/2009 08:59 PM Page 819 Aptara
LWB K34 0-c 3 5 _ _ p79 9-8 22. qx d 2 9 / 0 6 / / 2 009 0 8: 5 9 P M Pa g e 8 19 Apt ar a
0-c
K34
K34
8:
8:
5
qx
qx
C HAPTER 35 / Hypertension 819
57. Anderson, S. (2008). Pathogenesis of nephrosclerosis and chronic kidney College of Sports Medicine and the American Heart Association. Circu-
disease. In J. L. Izzo, D. Sica, & H. R. Black (Eds.), Hypertension primer: lation, 116, 1081–1093.
6
6
The essentials of high blood pressure (4th ed.). Philadelphia: Lippincott 81. Garrison, R. J., Kannel, W. B., Stokes J., III, et al. (1987). Incidence and
Williams & Wilkins. precursors of hypertension in young adults: The Framingham Offspring
6
58. National Kidney Foundation. (2004). K/DOQI clinical practice guide- Study. Preventive Medicine, 16, 235–251.
6
lines on hypertension and antihypertensive agents in chronic kidney dis- 82. Huang, Z., Willett, W. C., Manson, J. E., et al. (1998). Body weight,
ease. American Journal of Kidney Disease, 43(Suppl. 1), 1–290. weight change, and risk for hypertension in women. Annals of Internal
8
59. Wong, T. Y., & Mitchell, P. (2004). Hypertensive retinopathy. New Eng- Medicine, 128, 81–88.
land Journal of Medicine, 351, 2310–2317. 83. Blair, D., Habicht, J.-P., Sims, E. A., et al. (1984). Evidence for an increased
60. Collins, R., Peto, R., MacMahon, S., et al. (1990). Blood pressure, risk for hypertension with centrally located body fat and the effect of race
stroke, and coronary heart disease. Part 2, short-term reductions in blood and sex on this risk. American Journal of Epidemiology, 119, 526–540.
9
9
pressure: Overview of randomised drug trials in their epidemiological 84. Despres, J. P., Moorjani, S., Lupien, P. J., et al. (1990). Regional distri-
5
5
context. Lancet, 335, 827–838. bution of body fat, plasma lipoproteins, and cardiovascular disease. Arte-
61. Garraway, W. M., & Whisnant, J. P. (1987). The changing pattern of hy- riosclerosis, 10(4), 497–511.
8
pertension and the declining incidence of stroke. JAMA, 258, 214–217. 85. Folsom, A. R., Prineas, R. J., Kaye, S. A., et al. (1990). Incidence of hy-
62. Gueyffier, F., Boutitie, F., Boissel, J. P., et al. (1997). Effect of antihyperten- pertension and stroke in relation to body fat distribution and other risk
sive drug treatment on cardiovascular outcomes in women and men. A meta- factors in older women. Stroke, 21, 701–706.
analysis of individual patient data from randomized, controlled trials. The 86. Haarbo, J., Hassager, C., Riis, B. J., et al. (1989). Relation of body fat
INDANA Investigators. Annals of Internal Medicine, 126(10), 761–767. distribution to serum lipids and lipoproteins in elderly women. Athero-
6
6
63. MacMahon, S., Peto, R., Cutler, J., et al. (1990). Blood pressure, stroke, sclerosis, 80, 57–62.
0
0
and coronary heart disease. Part 1, prolonged differences in blood pres- 87. Ostlund, R. E., Staten, M., Kohrt, W. M., et al. (1990). The ratio of
sure: Prospective observational studies corrected for dilution bias. Lancet, waist-to-hip circumference, plasma insulin level, and glucose intolerance
5
5
335, 765–774. as independent predictors of the HDL 2 cholesterol level in elderly. New
2
2
64. Fotherby, M. D., Eveson, D. J., & Robinson, T. G. (2007). The brain in England Journal of Medicine, 322, 229–234.
hypertension. In G. Lip & J. E. Hall (Eds.), Comprehensive hypertension. 88. Stamler, R., Stamler, J., Riedlinger, W. F., et al. (1978). Weight and blood
Philadelphia: Mosby, Elsevier. pressure. Findings in hypertension screening of 1 million Americans.
65. Baumbach, G. L., & Heistad, D. D. (1999). Cerebrovascular disease in JAMA, 240(15), 1607–1610.
experimental models of hypertension. In J. D. Swales (Ed.), Textbook of 89. Manolio, T. A., Savage, P. J., Burke, G. L., et al. (1991). Correlates of
hypertension (pp. 682–690). Oxford, England: Blackwell Scientific. fasting insulin levels in young adults: The CARDIA study. Journal of
66. Pickering, T. G., Hall, J. E., Appel, L. J., et al. (2005). Recommendations Clinical Epidemiology, 44(6), 571–578.
4
4
for blood pressure measurement in humans and experimental animals. 90. Muller-Wieland, D., Kotzka, J., Knebel, B., et al. (1998). Metabolic syn-
5
5
Hypertension, 45, 142–161. drome and hypertension: Pathophysiology and molecular basis of insulin
67. Verdecchia, P., Schillaci, G., Borgioni, C., et al. (1996). Nocturnal pres- resistance. Basic Research in Cardiology, 93(Suppl. 2), 131–134.
sure is the true pressure. Blood Pressure Monitoring, 1(Suppl. 2), S81–S85. 91. Katagiri, H., Yamada, T., & Oka, Y. (2007). Adiposity and cardiovascu-
68. Pickering, T. G., Houston Miller, N., Ogedegbe, G., et al. (2008). Call lar disorders disturbance of the regulatory system consisting of humoral
to action on use and reimbursement for home blood pressure monitor- and neuronal signals. Circulation Research, 101, 27–39.
ing: Executive summary. A joint scientific statement from the American 92. Yanai, H., Tomono, Y., Ito, K., et al. (2008). The underlying mechanisms
Heart Association, American Society of Hypertension, and Preventive for development of hypertension in the metabolic syndrome. Nutrition
2
Cardiovascular Nurses Association. Hypertension, 52, 1–9. Journal, 7, 10.
2
69. Kaplan, N. M. (2002). Kaplan’s clinical hypertension (8th ed.). Philadel- 93. Hypertension Prevention Trial Research Group. (1990). The Hyperten-
phia: Lippincott Williams & Wilkins. sion Prevention Trial: Three-year effects of dietary changes on blood pres-
70. UK Prospective Diabetes Study Group. (1998). Tight blood pressure sure. Archives of Internal Medicine, 150, 153–162.
0
0
control and risk of macrovascular and microvascular complications in 94. Langford, H. G., Blaufox, M. D., Oberman, A., et al. (1985). Dietary
7
7
type 2 diabetes: UKPDS 38. BMJ, 317, 703–713. therapy slows the return of hypertension after stopping prolonged med-
71. Curb, J. D., Pressel, S. L., Cutler, J. A., et al. (1996). Effect of diuretic- ication. JAMA, 253, 657–664.
based antihypertensive treatment on cardiovascular disease risk in older 95. Trials of Hypertension Prevention Collaborative Research Group.
diabetic patients with isolated systolic hypertension. Systolic Hyperten- (1992). The effects of nonpharmacologic interventions on blood pressure
6
6
sion in the Elderly Program Cooperative Research Group. JAMA, 276, of persons with high normal levels. Results of the Trials of Hypertension
7
1886–1892. Prevention, Phase I. JAMA, 267, 1213–1220.
7
72. Staessen, J. A., Gasowski, J., Wang, J. G., et al. (2000). Risks of untreated 96. Trials of Hypertension Prevention Collaborative Research Group.
and treated isolated systolic hypertension in the elderly: Meta-analysis of (1997). Effects of weight loss and sodium reduction intervention on
outcome trials. Lancet, 355, 865–872. blood pressure and hypertension incidence in overweight people with
5
5
73. Staessen, J. A., Wang, J. G., & Thijs, L. (2003). Cardiovascular preven- high-normal blood pressure: The Trials of Hypertension Prevention,
7
7
tion and blood pressure reduction: A quantitative overview updated un- phase II. Archives of Internal Medicine, 157, 657–667.
til 1st March 2003. Journal of Hypertension, 21, 1055–1076. 97. Wassertheil-Smoller, S., Oberman, A., Blaufox, M. D., et al. (1992). The
74. He, J., Whelton, P. K., Appel, L. J., et al. (2000). Long-term effects of Trial of Antihypertensive Interventions and Management (TAIM) Study.
weight loss and dietary sodium reduction on incidence of hypertension. Final results with regard to blood pressure, cardiovascular risk, and qual-
5
Hypertension, 35(2), 544–549. ity of life. American Journal of Hypertension, 5, 37–44.
5
75. Stevens, V. J., Obarzanek, E., Cook, N. R., et al. (2001). Long-term 98. Neter, J. E., Stam, B. E., Kok, F. J., et al. (2003). Influence of weight re-
weight loss and changes in blood pressure: Results of the Trials of Hyper- duction on blood pressure: A meta-analysis of randomized controlled tri-
2
4
4
tension Prevention, phase II. Annals of Internal Medicine, 134(1), 1–11. als. Hypertension, 42, 878–884.
2
76. Whelton, P. K., He, J., Appel, L. J., et al. (2002). Primary prevention of 99. Neaton, J. D., Grimm, R. H., Prineas, R. J., et al. (1993). Treatment of
hypertension: Clinical and public health advisory from The National Mild Hypertension Study: Final results. JAMA, 270, 713–724.
0
0
High Blood Pressure Education Program. JAMA, 288(15), 1882–1888. 100. Oberman, A., Wassertheil-Smoller, S., Langford, H. G., et al. (1990).
77. Appel, L. J., Moore, T. J., Obarzanek, E., et al. (1997). A clinical trial of Pharmacologic and nutritional treatment of mild hypertension: Changes
2
the effects of dietary patterns on blood pressure. New England Journal of in cardiovascular risk status. Annals of Internal Medicine, 112, 89–95.
2
Medicine, 336, 1117–1124. 101. Arakawa, K. (1993). Hypertension and exercise. Clinical Experience in
6
6
78. John, J. H., Ziebland, S., Yudkin, P., et al. (2002). Effects of fruit and Hypertension, 15(6), 1171–1179.
vegetable consumption on plasma antioxidant concentrations and blood 102. Blair, S. N., Goodyear, N. N., Gibbons, L. W., et al. (1984). Physical fit-
pressure: A randomised controlled trial. Lancet, 359(9322), 1969–1974. ness and incidence of hypertension in healthy normotensive men and
79. Appel, L. J., Brands, M. W., Daniels, S. R., et al. (2006). Dietary ap- women. JAMA, 252, 487–490.
2
2
proaches to prevent and treat hypertension: A scientific statement from 103. Horan, M. J., & Lenfant, C. (1990). Epidemiology of blood pressure
the American Heart Association. Hypertension, 47, 296–308. and predictors of hypertension. Hypertension, 15(2, Suppl.), I20–I24.
7
7
80. Haskell, W. L., Lee, I. M., Pate, R. R., et al. (2007). Physical activity and 104. Ledoux, M., Lambert, J., Reeder, B. A., et al. (1997). Correlation be-
public health: Updated recommendation for adults from the American tween cardiovascular disease risk factors and simple anthropometric